Pharmaceutical Industry Blog

Why Farbe Firma is the Leading Injectable Manufacturer in Barbados Last Updated: 16 September 2026 TL;DR: Barbados has historically had no product registration requirement at all - the gate is commercial, not regulatory: an importer's licence, supplier registration with the Barbados Drug Service, a local agent and a place on the national formulary. That is now changing: the Barbados Medical Products Act, 2026 was passed in June 2026 and will introduce marketing authorisation,

Why Farbe Firma is the Leading Injectable Manufacturer in Vanuatu Last Updated: 16 September 2026 TL;DR: Vanuatu does not appear to operate pre-market product registration for medicines. The Sale of Medicines (Control) Act [CAP 48], as amended in 2014, regulates who may import and wholesale rather than which products may be sold, and the decisive check is a post-arrival release decision by the Principal Pharmacist. The practical gate is therefore your Vanuatu counterparty and

Why Farbe Firma is the Leading Injectable Manufacturer in the Bahamas Last Updated: 15 September 2026 TL;DR: The Bahamas has no product registration or marketing authorisation regime for medicines. The Pharmacy Act, 2009, consolidated as Chapter 227, runs to 52 sections and creates no drug register and no dossier assessment. What it creates instead is a pharmacopoeia standard and a premises-and-person licensing system run by the Bahamas Pharmacy Council. The Bahamas National

Why Farbe Firma is the Leading Injectable Manufacturer in Belize Last Updated: 15 September 2026 TL;DR: Belize has no standalone medicines agency. Authorisation sits with the Director of Health Services inside the Ministry of Health and Wellness, and the operative instrument is the Food and Drugs (Registration, Licensing and Inspection) Regulations 2017, S.I. No. 54 of 2017. That instrument requires genuine product registration rather than a bare import permit, and it names n

Last Updated: September 14, 2026 TL;DR: Brunei Darussalam's governing instrument is the Medicines Order, 2007, and product registration has been mandatory since July 2012 — but we found no reference-country list published by the authority itself. The benchmark list that circulates comes from a trade guide, and India is not among the countries it names, so India's absence is reported rather than verified. The best-evidenced requirement is the import licence: the applicant must

Last Updated: September 14, 2026 TL;DR: The Maldives Food and Drug Authority publishes a named list of Reference Regulatory Authorities in Annexure-I of its Guideline on Good Reliance Practice. We read all 45 entries and India is not among them, though MFDA itself describes the list as dynamic and subject to change. Reliance pathways are mandatory for parenterals; a WHO-GMP certificate issued by an Indian state licensing authority is not one of the enumerated grounds for exem